(Q42348458)

English

NOTCH1 mutation, TP53 alteration and myeloid antigen expression predict outcome heterogeneity in children with first relapse of T-cell acute lymphoblastic leukemia

scientific article published on 30 March 2017

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

27 October 2017

NOTCH1 mutation, TP53 alteration and myeloid antigen expression predict outcome heterogeneity in children with first relapse of T-cell acute lymphoblastic leukemia (English)

1 reference

Europe PubMed Central

27 October 2017

T-cell acute lymphoblastic leukemia

1 reference

based on heuristic

inferred from title

Obul R. Bandapalli

object named as

Obul R Bandapalli

4

0 references

Arend von Stackelberg

15

object named as

Arend von Stackelberg

1 reference

Europe PubMed Central

27 October 2017

Renate Kirschner-Schwabe

16

object named as

Renate Kirschner-Schwabe

1 reference

Europe PubMed Central

27 October 2017

Stefanie Groeneveld-Krentz

3

object named as

Stefanie Groeneveld-Krentz

1 reference

Europe PubMed Central

27 October 2017

Martina U Muckenthaler

13

object named as

Martina U Muckenthaler

1 reference

Europe PubMed Central

27 October 2017

author name string

Jana Hof

1

1 reference

Europe PubMed Central

27 October 2017

Corinne Kox

2

1 reference

Europe PubMed Central

27 October 2017

Leonid Karawajew

5

1 reference

Europe PubMed Central

27 October 2017

Katharina Schedel

6

1 reference

Europe PubMed Central

27 October 2017

Joachim B Kunz

7

1 reference

Europe PubMed Central

27 October 2017

Cornelia Eckert

8

1 reference

Europe PubMed Central

27 October 2017

Wolf-Dieter Ludwig

9

1 reference

Europe PubMed Central

27 October 2017

Richard Ratei

10

1 reference

Europe PubMed Central

27 October 2017

Peter Rhein

11

1 reference

Europe PubMed Central

27 October 2017

Günter Henze

12

1 reference

Europe PubMed Central

27 October 2017

Andreas E Kulozik

14

1 reference

Europe PubMed Central

27 October 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

30 March 2017

1 reference

Europe PubMed Central

27 October 2017

1 reference

Europe PubMed Central

27 October 2017

102

1 reference

Europe PubMed Central

27 October 2017

7

1 reference

Europe PubMed Central

27 October 2017

e249-e252

1 reference

Europe PubMed Central

27 October 2017

RNA sequencing unravels the genetics of refractory/relapsed T-cell acute lymphoblastic leukemia. Prognostic and therapeutic implications

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5566048

29 May 2018

Early T-cell precursor acute lymphoblastic leukaemia in children treated in AIEOP centres with AIEOP-BFM protocols: a retrospective analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5566048

29 May 2018

Early T-cell precursor acute lymphoblastic leukemia/lymphoma (ETP-ALL/LBL) in adolescents and adults: a high-risk subtype

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5566048

29 May 2018

Impact of PTEN abnormalities on outcome in pediatric patients with T-cell acute lymphoblastic leukemia treated on the MRC UKALL2003 trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5566048

29 May 2018

NOTCH1 activation clinically antagonizes the unfavorable effect of PTEN inactivation in BFM-treated children with precursor T-cell acute lymphoblastic leukemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5566048

29 May 2018

Mutations and deletions of the TP53 gene predict nonresponse to treatment and poor outcome in first relapse of childhood acute lymphoblastic leukemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5566048

29 May 2018

The favorable effect of activating NOTCH1 receptor mutations on long-term outcome in T-ALL patients treated on the ALL-BFM 2000 protocol can be separated from FBXW7 loss of function

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5566048

29 May 2018

Early T-cell precursor leukaemia: a subtype of very high-risk acute lymphoblastic leukaemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5566048

29 May 2018

Toward a NOTCH1/FBXW7/RAS/PTEN-based oncogenetic risk classification of adult T-cell acute lymphoblastic leukemia: a Group for Research in Adult Acute Lymphoblastic Leukemia study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5566048

17 August 2018

Lineage classification of childhood acute lymphoblastic leukemia according to the EGIL recommendations: results of the ALL-BFM 2000 trial.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5566048

17 August 2018

Impact of NOTCH1/FBXW7 mutations on outcome in pediatric T-cell acute lymphoblastic leukemia patients treated on the MRC UKALL 2003 trial.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5566048

17 August 2018

NOTCH1 and FBXW7 mutations have a favorable impact on early response to treatment, but not on outcome, in children with T-cell acute lymphoblastic leukemia (T-ALL) treated on EORTC trials 58881 and 58951.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5566048

17 August 2018

NOTCH1 and/or FBXW7 mutations predict for initial good prednisone response but not for improved outcome in pediatric T-cell acute lymphoblastic leukemia patients treated on DCOG or COALL protocols

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5566048

17 August 2018

Long-term outcome in children with relapsed acute lymphoblastic leukemia after time-point and site-of-relapse stratification and intensified short-course multidrug chemotherapy: results of trial ALL-REZ BFM 90.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5566048

17 August 2018

Clinical significance of p53 mutations in relapsed T-cell acute lymphoblastic leukemia.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5566048

17 August 2018

Analysis of p53 mutations in a large series of lymphoid hematologic malignancies of childhood

1 reference

https://pubmed.ncbi.nlm.nih.gov/28360149

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

How I treat relapsed childhood acute lymphoblastic leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/28360149

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Significance of commonly used prognostic factors differs for children with T cell acute lymphocytic leukemia (ALL), as compared to those with B-precursor ALL. A Pediatric Oncology Group (POG) study

1 reference

https://pubmed.ncbi.nlm.nih.gov/28360149

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.3324/HAEMATOL.2016.157792

1 reference

Europe PubMed Central

27 October 2017

1 reference

Europe PubMed Central

27 October 2017

1 reference

Europe PubMed Central

27 October 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42348458&oldid=1631920304"